# SOOLANTRA
> **NDA206255** · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2014-12-19
## Drug
- **FDA Application Number:** NDA206255
- **Application type:** New Drug Application
- **Brand name:** SOOLANTRA
- **Generic name:** IVERMECTIN
- **Active ingredients:** IVERMECTIN
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** GALDERMA LABS LP
- **Manufacturer:** Galderma Laboratories, L.P.
- **First approval:** 2014-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206255)
---
*AI Analytics · CC0 1.0*